Glimepiride
Amaryl, Tandemact (glimepiride) is a small molecule pharmaceutical. Glimepiride was first approved as Amaryl on 1995-11-30. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus.
| Trade Name | Tandemact |
|---|---|
| Common Name | Glimepiride |
| Indication | type 2 diabetes mellitus |
| Drug Class | Antihyperglycemics |
